Format

Send to

Choose Destination
Minerva Chir. 2017 Apr;72(2):146-156. doi: 10.23736/S0026-4733.16.07261-8. Epub 2016 Dec 16.

Up-regulation of Flot-2 protein is related to lymph node metastasis and poor prognosis in human solid tumors.

Author information

1
Department of General Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang, China.
2
The Fourth Clinical College of Nanchang University, Nanchang, China.
3
Department of General Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang, China - zzm8654@163.com.

Abstract

INTRODUCTION:

Numerous studies showed that the Flot-2 protein expression was significantly elevated in cancerous tissues and Flot-2 played pivotal roles in the development and progression of cancers. Increased expression of Flot-2 was correlated to a poor prognosis in cancer patients.

EVIDENCE ACQUISITION:

Eligible literatures were collected by retrieving multiple databases, including PubMed, Web of Science, Embase, CNKI and Wanfang database. With RevMan5.3 software and Stata SE12.0, the association of Flot-2 expression level with lymph node metastasis (LNM) and overall survival (OS) were explored in cancer patients.

EVIDENCE SYNTHESIS:

A total of 1947 cancer patients from 13 eligible articles were included in this meta-analysis. The results indicated that patients with over-expressed Flot-2 would develop an increased risk of LNM (OR=2.58, 95% CI: 1.60-4.16, P=0.0001), as well as shorter OS (HR=1.59, 95% CI: 1.13-2.06, P=0.000), compared to those patients with lower expression of Flot-2 in tumor tissues.

CONCLUSIONS:

Flot-2 protein might be a novel biomarker; LNM and OS may be predicted by up-regulated expression of Flot-2 in various tumors.

PMID:
27981826
DOI:
10.23736/S0026-4733.16.07261-8
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Minerva Medica
Loading ...
Support Center